Patents Assigned to OPKO IRELAND GLOBAL HOLDINGS, LIMITED
  • Method for treating secondary hyperparathyroidism in CKD
    Patent number: 9925147
    Abstract: A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: March 27, 2018
    Assignees: OPKO RENAL, LLC, OPKO IRELAND GLOBAL HOLDINGS, LIMITED
    Inventors: Charles W. Bishop, Samir P. Tabash, Sammy A. Agudoawu, Jay A. White, Eric J. Messner, P. Martin Petkovich, Keith H. Crawford